636 related articles for article (PubMed ID: 24662516)
1. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
[TBL] [Abstract][Full Text] [Related]
2. Oligomer-prone E57K-mutant alpha-synuclein exacerbates integration deficit of adult hippocampal newborn neurons in transgenic mice.
Regensburger M; Schreglmann SR; Stoll S; Rockenstein E; Loskarn S; Xiang W; Masliah E; Winner B
Brain Struct Funct; 2018 Apr; 223(3):1357-1368. PubMed ID: 29124353
[TBL] [Abstract][Full Text] [Related]
3. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
[TBL] [Abstract][Full Text] [Related]
4. α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.
Lim Y; Kehm VM; Lee EB; Soper JH; Li C; Trojanowski JQ; Lee VM
J Neurosci; 2011 Jul; 31(27):10076-87. PubMed ID: 21734300
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.
Overk CR; Cartier A; Shaked G; Rockenstein E; Ubhi K; Spencer B; Price DL; Patrick C; Desplats P; Masliah E
Mol Neurodegener; 2014 May; 9():18. PubMed ID: 24885390
[TBL] [Abstract][Full Text] [Related]
8. Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy.
Singh B; Covelo A; Martell-Martínez H; Nanclares C; Sherman MA; Okematti E; Meints J; Teravskis PJ; Gallardo C; Savonenko AV; Benneyworth MA; Lesné SE; Liao D; Araque A; Lee MK
Acta Neuropathol; 2019 Oct; 138(4):551-574. PubMed ID: 31168644
[TBL] [Abstract][Full Text] [Related]
9. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
10. Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model.
Behere A; Thörnqvist PO; Winberg S; Ingelsson M; Bergström J; Ekmark-Lewén S
J Neurosci Res; 2021 Oct; 99(10):2525-2539. PubMed ID: 34292621
[TBL] [Abstract][Full Text] [Related]
11. Neuropathology in mice expressing human alpha-synuclein.
van der Putten H; Wiederhold KH; Probst A; Barbieri S; Mistl C; Danner S; Kauffmann S; Hofele K; Spooren WP; Ruegg MA; Lin S; Caroni P; Sommer B; Tolnay M; Bilbe G
J Neurosci; 2000 Aug; 20(16):6021-9. PubMed ID: 10934251
[TBL] [Abstract][Full Text] [Related]
12. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
[TBL] [Abstract][Full Text] [Related]
13. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
Volpicelli-Daley LA; Luk KC; Patel TP; Tanik SA; Riddle DM; Stieber A; Meaney DF; Trojanowski JQ; Lee VM
Neuron; 2011 Oct; 72(1):57-71. PubMed ID: 21982369
[TBL] [Abstract][Full Text] [Related]
14. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
[TBL] [Abstract][Full Text] [Related]
15. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
[TBL] [Abstract][Full Text] [Related]
16. Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.
Games D; Seubert P; Rockenstein E; Patrick C; Trejo M; Ubhi K; Ettle B; Ghassemiam M; Barbour R; Schenk D; Nuber S; Masliah E
Am J Pathol; 2013 Mar; 182(3):940-53. PubMed ID: 23313024
[TBL] [Abstract][Full Text] [Related]
17. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.
Garcia-Reitböck P; Anichtchik O; Bellucci A; Iovino M; Ballini C; Fineberg E; Ghetti B; Della Corte L; Spano P; Tofaris GK; Goedert M; Spillantini MG
Brain; 2010 Jul; 133(Pt 7):2032-44. PubMed ID: 20534649
[TBL] [Abstract][Full Text] [Related]
18. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation.
Fagerqvist T; Lindström V; Nordström E; Lord A; Tucker SM; Su X; Sahlin C; Kasrayan A; Andersson J; Welander H; Näsström T; Holmquist M; Schell H; Kahle PJ; Kalimo H; Möller C; Gellerfors P; Lannfelt L; Bergström J; Ingelsson M
J Neurochem; 2013 Jul; 126(1):131-44. PubMed ID: 23363402
[TBL] [Abstract][Full Text] [Related]
20. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.
Schulz-Schaeffer WJ
Acta Neuropathol; 2010 Aug; 120(2):131-43. PubMed ID: 20563819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
